Physician profile
Jennifer Hawkins
NPI 1942049572
$2,874.18
in general payments reported to CMS, 2019-2025
23 companies · $2,034 in 2025
The $2,034 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $840 · 2025: $2,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,750 · Education: $82.06 · Gift: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,749.62 |
| Education | $82.06 |
| Gift | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $747.37 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Madrigal Pharmaceuticals | $591.97 | 2024-2025 | Rezdiffra, Resmetirom |
| Xeris Pharmaceuticals, INC. | $192.63 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $185.74 | 2024-2025 | Korlym |
| Novo Nordisk INC | $179.37 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $131.86 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Mannkind Corporation | $119.05 | 2024-2025 | |
| Radius Health, INC. | $112.13 | 2024-2025 | Tymlos |
| Recordati_rare_diseases_inc. | $88.37 | 2025 | Isturisa |
| Insulet Corporation | $81.01 | 2024-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $76.69 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $57.29 | 2024-2025 | Lokelma, Farxiga |
| Cequr Corporation | $52.53 | 2024 | Cequr Simplicity |
| Medtronic, INC. | $43.30 | 2025 | Minimed 780g |
| Abbvie INC. | $37.34 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $33.83 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Becton, Dickinson and Company | $31.02 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.21 | 2024 | |
| Verity Pharmaceuticals INC. | $20.42 | 2024 | Tlando |
| Amneal Pharmaceuticals LLC | $17.80 | 2024 | Unithroid |
| Astellas Pharma US INC | $17.28 | 2024 | Veozah |
| Inspire Medical Systems, INC. | $16.62 | 2025 | Inspire |
| Tolmar, INC. | $14.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.